» Articles » PMID: 26272882

Boosting Vaccine Efficacy the Natural (killer) Way

Overview
Journal Trends Immunol
Date 2015 Aug 15
PMID 26272882
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Coordination of the innate and adaptive immune systems is paramount to the development of protective humoral and cellular immunity following vaccination. Natural killer (NK) cells are front-line soldiers of the innate immune system, and recent studies have revealed functions for NK cells in long-lived immune memory and the regulation of adaptive immune responses. These findings suggest that NK cells may play important roles in the development of efficacious vaccines, as well as, in some contexts, failed immunizations. Here, we review the current understanding of the immunomodulatory and memory differentiation capabilities of NK cells. We examine the context dependency of the mechanisms and the nature of NK cell-mediated modulation of the immune response, and discuss how these insights may impact immunization strategies and the development of next-generation vaccines.

Citing Articles

Germline natural killer cell receptors modulating the T cell response.

Mora-Bitria L, Asquith B Front Immunol. 2024; 15:1477991.

PMID: 39559364 PMC: 11570266. DOI: 10.3389/fimmu.2024.1477991.


Premature skewing of T cell receptor clonality and delayed memory expansion in HIV-exposed infants.

Dzanibe S, Wilk A, Canny S, Ranganath T, Alinde B, Rubelt F Nat Commun. 2024; 15(1):4080.

PMID: 38744812 PMC: 11093981. DOI: 10.1038/s41467-024-47955-5.


Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates.

Schramm C, Moon D, Peyton L, Lima N, Wake C, Boswell K Nat Commun. 2023; 14(1):7961.

PMID: 38042809 PMC: 10693617. DOI: 10.1038/s41467-023-43420-x.


Sequence of COVID-19 Vaccination and COVID-19 Infection and Their Association With the Development of Active Tuberculosis: A Case-Control Study.

Palupi S, Pambudi I, Surya A, Bramanthi R, Arfi M, Suyanto S Cureus. 2023; 15(10):e46353.

PMID: 37790868 PMC: 10544859. DOI: 10.7759/cureus.46353.


Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination.

Pinder C, Jankovic D, Fox T, Kirkwood A, Enfield L, Alrubayyi A Br J Haematol. 2023; 202(6):1091-1103.

PMID: 37402627 PMC: 10953351. DOI: 10.1111/bjh.18962.


References
1.
Alter G, Sekaly R . Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity. Vaccine. 2015; 33 Suppl 2:B55-9. DOI: 10.1016/j.vaccine.2015.03.058. View

2.
Storkus W, Dawson J . B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation. J Immunol. 1986; 136(5):1542-7. View

3.
Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A . Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 2007; 110(2):606-15. DOI: 10.1182/blood-2006-10-052720. View

4.
Westwood J, Kelly J, Tanner J, Kershaw M, Smyth M, Hayakawa Y . Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway. J Immunol. 2004; 172(2):757-61. DOI: 10.4049/jimmunol.172.2.757. View

5.
Paust S, Gill H, Wang B, Flynn M, Moseman E, Senman B . Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol. 2010; 11(12):1127-35. PMC: 2982944. DOI: 10.1038/ni.1953. View